Alteration in ornithine metabolism due to mutation in ALDH18A1 masquerading as ALS in pregnancy

Amyotroph Lateral Scler Frontotemporal Degener. 2025 Feb;26(1-2):172-174. doi: 10.1080/21678421.2024.2410982. Epub 2024 Oct 3.

Abstract

Clinical onset and exacerbation of autosomal dominant SPG9A hereditary spastic paraplegia, including reversible wasting, has been described during pregnancy. SPG9A is due to ALDH18A1 mutations resulting in proline and ornithine deficiency. We present the case of a 29 year old primagravida at 32 weeks who presented with six months of upper limb amyotrophic wasting on a background unrecognized progressive spasticity due to SPG9A. The wasting reversed significantly following delivery. Our report highlights the unusual clinical features including cataract and joint laxity which may suggest SPG9A, echoes the existing descriptions of pregnancy-related provocation of amyotrophy in this condition and documents the outcome of two subsequent pregnancies following dietary intervention.

Keywords: ALDH181A; Hereditary spastic paraplegia; amyotrophy; ornithine; pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aldehyde Dehydrogenase / genetics
  • Amyotrophic Lateral Sclerosis* / diagnosis
  • Amyotrophic Lateral Sclerosis* / genetics
  • Diagnosis, Differential
  • Female
  • Humans
  • Mutation* / genetics
  • Ornithine* / blood
  • Pregnancy
  • Pregnancy Complications / diagnosis
  • Pregnancy Complications / genetics
  • Spastic Paraplegia, Hereditary / diagnosis
  • Spastic Paraplegia, Hereditary / genetics

Substances

  • ALDH18A1 protein, human
  • Ornithine
  • Aldehyde Dehydrogenase